MESO

Mesoblast Ltd (MESO)

US
$ 11.914.93%

Price Chart

Key Statistics

Market Cap
$ 1.47B
P/E Ratio
0.00
Revenue (TTM)
$ 5.67M
Volume
215.21K
52W High
$ 22.00
52W Low
$ 5.78
Dividend Yield
0.00%
Beta
1.43

Technicals

50-Day MA
11.9026
200-Day MA
11.7612
52 Week High
22
52 Week Low
5.78

About MESO

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. Its proprietary regenerative medicine technology platform is.

Employees
73
Headquarters
Melbourne, VIC
CEO
Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg